InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Evan Loh, CEO, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 10 open-market SEC Form 4 transactions: 0 purchases worth $0 and 10 sales worth $1.0M, reported from Aug 17, 21 to Aug 9, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 9, 23 | PRTKParatek Pharmaceuticals, Inc. | SELL | 49.0K | $2.20 | $108K |
| Dec 21, 22 | PRTKParatek Pharmaceuticals, Inc. | SELL | 23.5K | $1.99 | $47K |
| Dec 13, 22 | PRTKParatek Pharmaceuticals, Inc. | SELL | 61.9K | $1.96 | $121K |
| Dec 12, 22 | PRTKParatek Pharmaceuticals, Inc. | SELL | 37.8K | $1.98 | $75K |
| Oct 28, 22 | PRTKParatek Pharmaceuticals, Inc. | SELL | 8.8K | $3.47 | $31K |
| Aug 9, 22 | PRTKParatek Pharmaceuticals, Inc. | SELL | 44.5K | $2.66 | $118K |
| Dec 15, 21 | PRTKParatek Pharmaceuticals, Inc. | SELL | 49.3K | $4.27 | $210K |
| Dec 14, 21 | PRTKParatek Pharmaceuticals, Inc. | SELL | 23.8K | $4.37 | $104K |
| Dec 13, 21 | PRTKParatek Pharmaceuticals, Inc. | SELL | 14.0K | $4.42 | $62K |
| Aug 17, 21 | PRTKParatek Pharmaceuticals, Inc. | SELL | 33.9K | $5.12 | $174K |